Código QR

Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary

A new therapeutic class of oral agents firstly used for the treatment of type 2 diabetes mellitus is represented by gliflozines or sodium-glucose co-transporter 2 (SGLT2) inhibitors. SGLT2 inhibitors might be effective alone or in combination with any other drugs. This therapeutic class currently in...

Descripción completa

Guardado en:
Autores principales: Annamaria Mascolo, Raffaella Di Napoli, Nunzia Balzano, Donato Cappetta, Konrad Urbanek, Antonella De Angelis, Lucia Scisciola, Irene Di Meo, Maria Giuseppa Sullo, Concetta Rafaniello, Liberata Sportiello
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2022-09-01
Colección:Frontiers in Cardiovascular Medicine
Materias:
safety
SGLT2 (sodium-glucose cotransporter 2) inhibitor
adverse drug (event)
evidence medicine
review
Acceso en línea:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1010693/full
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares